Anna Zganiacz
Overview
Explore the profile of Anna Zganiacz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
1137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jeyanathan M, Vaseghi-Shanjani M, Afkhami S, Grondin J, Kang A, DAgostino M, et al.
Nat Immunol
. 2023 May;
24(6):1049.
PMID: 37161093
No abstract available.
2.
Kang A, Ye G, Singh R, Afkhami S, Bavananthasivam J, Luo X, et al.
EMBO Mol Med
. 2023 May;
15(7):e17084.
PMID: 37158369
Bacillus Calmette-Guérin (BCG) still remains the only licensed vaccine for TB and has been shown to provide nonspecific protection against unrelated pathogens. This has been attributed to the ability of...
3.
Jeyanathan V, Afkhami S, DAgostino M, Zganiacz A, Feng X, Miller M, et al.
Front Immunol
. 2023 Feb;
14:1151809.
PMID: 36825013
[This corrects the article DOI: 10.3389/fimmu.2022.860399.].
4.
Afkhami S, DAgostino M, Vaseghi-Shanjani M, Lepard M, Yang J, Lai R, et al.
NPJ Vaccines
. 2023 Feb;
8(1):25.
PMID: 36823425
Viral-vectored vaccines are highly amenable for respiratory mucosal delivery as a means of inducing much-needed mucosal immunity at the point of pathogen entry. Unfortunately, current monovalent viral-vectored tuberculosis (TB) vaccine...
5.
Jeyanathan M, Vaseghi-Shanjani M, Afkhami S, Grondin J, Kang A, DAgostino M, et al.
Nat Immunol
. 2022 Dec;
23(12):1687-1702.
PMID: 36456739
Aside from centrally induced trained immunity in the bone marrow (BM) and peripheral blood by parenteral vaccination or infection, evidence indicates that mucosal-resident innate immune memory can develop via a...
6.
Lepard M, Yang J, Afkhami S, Nazli A, Zganiacz A, Tang S, et al.
Viruses
. 2022 Sep;
14(9).
PMID: 36146734
In people living with HIV, () is the major cause of death. Due to the increased morbidity/mortality in co-infection, further research is urgently required. A limiting factor to research in...
7.
Jeyanathan V, Afkhami S, DAgostino M, Zganiacz A, Feng X, Miller M, et al.
Front Immunol
. 2022 Jun;
13:860399.
PMID: 35757753
Infectious diseases of the respiratory tract are one of the top causes of global morbidity and mortality with lower respiratory tract infections being the fourth leading cause of death. The...
8.
Afkhami S, DAgostino M, Zhang A, Stacey H, Marzok A, Kang A, et al.
Cell
. 2022 Feb;
185(5):896-915.e19.
PMID: 35180381
The emerging SARS-CoV-2 variants of concern (VOCs) threaten the effectiveness of current COVID-19 vaccines administered intramuscularly and designed to only target the spike protein. There is a pressing need to...
9.
Jeyanathan M, Fritz D, Afkhami S, Aguirre E, Howie K, Zganiacz A, et al.
JCI Insight
. 2022 Jan;
7(3).
PMID: 34990408
BackgroundAdenovirus-vectored (Ad-vectored) vaccines are typically administered via i.m. injection to humans and are incapable of inducing respiratory mucosal immunity. However, aerosol delivery of Ad-vectored vaccines remains poorly characterized, and its...
10.
DAgostino M, Lai R, Afkhami S, Khera A, Yao Y, Vaseghi-Shanjani M, et al.
J Immunol
. 2020 Oct;
205(10):2750-2762.
PMID: 32998983
, the causative agent of pulmonary tuberculosis (TB), is responsible for millions of infections and deaths annually. Decades of TB vaccine development have focused on adaptive T cell immunity, whereas...